Symptoms of Cannabinoid Hyperemesis Syndrome (CHS) include nausea, vomiting, and abdominal cramps, but the condition can also be fatal. There are a number of treatments available, but the cause of the condition is unknown. Here are some of the key things you need to know about the condition.
Symptoms
Symptoms of cannabinoid hyperemesis syndrome (CHS) include severe vomiting and abdominal pain. This condition is caused by chronic marijuana use. This condition may be treated with drugs or by abstaining from marijuana. Symptoms of CHS usually resolve within a few days. However, in some cases, CHS can persist for years.
CHS may affect people of any age. However, most cases involve people between the ages of 18 and 40. People who smoke marijuana heavily are more likely to develop CHS. The condition is also more prevalent in those who smoke cannabis more than a few times a week.
CHS can cause dehydration and other negative effects. Dehydration can lead to organ failure, seizures, and other life-threatening injuries. In addition, severe vomiting may cause chemical abnormalities that can lead to harmful health conditions.
There is no specific dosage that will cause CHS, although marijuana users who smoke high amounts of THC may be at greater risk. A typical CHS patient has been using marijuana for years before developing symptoms.
Symptoms of cannabinoid hyperemesis syndrome may include extreme vomiting, diarrhea, and abdominal pain. Some people also experience physical symptoms such as fatigue and weight loss.
The condition is difficult to treat. Some people with CHS are forced to stay in hospitals until the symptoms go away. The condition is also accompanied by emotional distress.
The most effective treatment for cannabinoid hyperemesis syndrome is to stop using marijuana. However, stopping marijuana use is not easy. The symptoms of CHS may continue to recur when marijuana use resumes.
Some people may be tempted to try marijuana again after the symptoms subside. However, this is not recommended. The only true cure for CHS is to stop using marijuana. In addition, a comprehensive treatment program may help you stabilize your body and help you stop using marijuana.
There are no hard and fast statistics on the number of cases of cannabinoid hyperemesis syndrome each year. However, doctors believe that the availability of stronger THC cannabis is contributing to the increased prevalence of the condition.
It is important to recognize the signs of cannabinoid hyperemesis Syndrome before they turn into a serious medical condition. If you think you may have a cannabis use disorder, contact a doctor.
Diagnosis
Symptoms of Cannabinoid Hyperemesis Syndrome (CHS) are extreme nausea, vomiting, and abdominal pain that may last for days or even weeks. Although these symptoms may not appear when the person first starts smoking marijuana, they may develop later in life.
The onset of CHS symptoms is associated with prolonged and heavy marijuana use. People who experience these symptoms may also have a cannabis use disorder. This disorder is a chronic condition that may require professional treatment to help manage it. If you have CHS, you may need to stop using cannabis, especially if you think it will ease your symptoms. However, if you are a chronic user, the symptoms may recur when you stop using.
CHS may be fatal in some cases. When a person suffers from extreme vomiting, they may experience dehydration or chemical abnormalities in the body. This may lead to kidney failure and cardiac arrest. This is why it is so important to get medical treatment if you have this condition.
The causes of CHS are not yet fully understood. Some doctors believe that frequent use of cannabis may overstimulate the endocannabinoid system and throw it off balance. Other theories suggest that CHS may be associated with chemotherapy and other cancer treatments.
Some of the symptoms of Cannabinoid Hyperemesis syndrome include nausea, vomiting, abdominal pain, and scrolling. In addition, people with CHS may have suicidal thoughts.
Many people who experience CHS do not seek medical treatment. They may try to restart marijuana use once the symptoms are gone. However, this will only make the symptoms worse. This is because the endocannabinoid and nervous systems are overstimulated by the frequent use of marijuana.
While a few studies have shown that cannabis can relieve symptoms of CHS, the results do not apply to everyone. Some studies show that benzodiazepines, aprepitant, and droperidol provide symptom relief.
One patient who died of CHS had a 20-year history of frequent marijuana use. He developed recurrent prolonged episodes of nausea and vomiting. Several ED visits were made. Symptoms responded well to hot water hydrotherapy, but his condition worsened after he stopped using marijuana.
Treatment Options
Symptoms of cannabinoid hyperemesis syndrome (CHS) are severe nausea, vomiting, and abdominal pain. The symptoms usually last for a few days. The condition is related to the long-term use of marijuana.
There are three main phases of the disease. The prodromal phase can last for years in some cases. People who develop CHS have chronic marijuana use. They may begin using marijuana to feel better, only to increase their use when they feel sick. The recurrent bouts of sickness can be uncontrollable and result in long hospital stays.
There are three main theories about the cause of CHS. One of these theories suggests that the effect of cannabis on the CB1 receptor is the cause. Another theory involves cannabinoid lipid buildup in the body. A third theory suggests that gastrointestinal CB1 overriding is the cause.
Treatment options for cannabinoid hyperemesis syndrome include hot water hydrotherapy. There is also evidence that benzodiazepines and propranolol provide symptom relief. However, the effect of these medications is still unclear.
Other treatment options include the use of opioids. However, opioids are not effective. Benzodiazepines and gabapentin may be useful. However, it is still unclear whether opioids are appropriate in the treatment of CHS.
There are also anecdotal reports of patients suffering from CHS, but they may not be representative of the wider population. It is important to view these reports in a context of controlled research.
Often, the patient has a history of cannabis use, but it is not clear whether cannabis causes CHS. The patient also has a history of recurrent N/V. Some patients also have other drug abuse problems. However, the majority of patients reported a history of cannabis use.
The clinical presentation of CHS is often subtle, and can be missed during the early stages of the illness. However, delays in diagnosis can result in significant morbidity or even death. A rapid diagnosis is crucial.
A comprehensive treatment program can help stabilize the patient’s body and support cessation. Patients who have been diagnosed with CHS are advised to stop marijuana use. The Substance Abuse and Mental Health Services Administration offers a 24-hour helpline in English.
Overlapping With Other Conditions
Despite the growing prevalence of cannabis hyperemesis syndrome (CHS), there are only limited data about its incidence and prevalence. However, medical sources suggest that CHS will become more prevalent as nationwide cannabis use increases. In this systematic review, we aim to identify the management options available for patients suffering from this condition.
In the search for articles, we used PubMed, EMBASE, Cochrane Central, Google Scholar, and Ovid MEDLINE. We found 17 articles deemed relevant to our review. These articles were then reviewed and summarized using an Excel sheet. The articles were categorized according to their study objective. Several of the articles cited were clinical case reports that described episodic nausea and hypereremesis.
The studies found showed that the onset of CHS was preceded by heavy cannabis use. However, there is little evidence to support the effectiveness of cannabis and other cannabinoids in preventing emetic episodes. Other treatments, such as benzodiazepines, haloperidol, and propranolol, have shown some relief.
Although there is a lot of controversy about the diagnostic criteria for CHS, it is commonly known that the disease shares many clinical features with cyclic vomiting syndrome. This makes the characterization of CHS very difficult. It is also difficult to prove whether cannabinoids have an antiemetic effect or if they contribute to the emetic symptoms. There is also limited follow up, which makes it difficult to determine whether the condition is causal.
